BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25053638)

  • 1. SCN10A/Nav1.8 modulation of peak and late sodium currents in patients with early onset atrial fibrillation.
    Savio-Galimberti E; Weeke P; Muhammad R; Blair M; Ansari S; Short L; Atack TC; Kor K; Vanoye CG; Olesen MS; LuCamp ; Yang T; George AL; Roden DM; Darbar D
    Cardiovasc Res; 2014 Nov; 104(2):355-63. PubMed ID: 25053638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common and rare variants in SCN10A modulate the risk of atrial fibrillation.
    Jabbari J; Olesen MS; Yuan L; Nielsen JB; Liang B; Macri V; Christophersen IE; Nielsen N; Sajadieh A; Ellinor PT; Grunnet M; Haunsø S; Holst AG; Svendsen JH; Jespersen T
    Circ Cardiovasc Genet; 2015 Feb; 8(1):64-73. PubMed ID: 25691686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common SCN10A variants modulate PR interval and heart rate response during atrial fibrillation.
    Delaney JT; Muhammad R; Shi Y; Schildcrout JS; Blair M; Short L; Roden DM; Darbar D
    Europace; 2014 Apr; 16(4):485-90. PubMed ID: 24072447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study.
    Behr ER; Savio-Galimberti E; Barc J; Holst AG; Petropoulou E; Prins BP; Jabbari J; Torchio M; Berthet M; Mizusawa Y; Yang T; Nannenberg EA; Dagradi F; Weeke P; Bastiaenan R; Ackerman MJ; Haunso S; Leenhardt A; Kääb S; Probst V; Redon R; Sharma S; Wilde A; Tfelt-Hansen J; Schwartz P; Roden DM; Bezzina CR; Olesen M; Darbar D; Guicheney P; Crotti L; ; Jamshidi Y
    Cardiovasc Res; 2015 Jun; 106(3):520-9. PubMed ID: 25691538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal Nav1.8 Channels as a Novel Therapeutic Target of Acute Atrial Fibrillation Prevention.
    Chen X; Yu L; Shi S; Jiang H; Huang C; Desai M; Li Y; Barajas-Martinez H; Hu D
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27806967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variant Intronic Enhancer Controls
    Man JCK; Bosada FM; Scholman KT; Offerhaus JA; Walsh R; van Duijvenboden K; van Eif VWW; Bezzina CR; Verkerk AO; Boukens BJ; Barnett P; Christoffels VM
    Circulation; 2021 Jul; 144(3):229-242. PubMed ID: 33910361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel SCN10A variants associated with Brugada syndrome.
    Fukuyama M; Ohno S; Makiyama T; Horie M
    Europace; 2016 Jun; 18(6):905-11. PubMed ID: 25842276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of functional studies on exome sequence variant interpretation in early-onset cardiac conduction system diseases.
    Hayashi K; Teramoto R; Nomura A; Asano Y; Beerens M; Kurata Y; Kobayashi I; Fujino N; Furusho H; Sakata K; Onoue K; Chiang DY; Kiviniemi TO; Buys E; Sips P; Burch ML; Zhao Y; Kelly AE; Namura M; Kita Y; Tsuchiya T; Kaku B; Oe K; Takeda Y; Konno T; Inoue M; Fujita T; Kato T; Funada A; Tada H; Hodatsu A; Nakanishi C; Sakamoto Y; Tsuda T; Nagata Y; Tanaka Y; Okada H; Usuda K; Cui S; Saito Y; MacRae CA; Takashima S; Yamagishi M; Kawashiri MA; Takamura M
    Cardiovasc Res; 2020 Nov; 116(13):2116-2130. PubMed ID: 31977013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
    El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
    Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of SCN10A variants in several cases of sudden unexplained death.
    Gando I; Williams N; Fishman GI; Sampson BA; Tang Y; Coetzee WA
    Forensic Sci Int; 2019 Aug; 301():289-298. PubMed ID: 31195250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Functional Na
    Casini S; Marchal GA; Kawasaki M; Nariswari FA; Portero V; van den Berg NWE; Guan K; Driessen AHG; Veldkamp MW; Mengarelli I; de Groot JR; Verkerk AO; Remme CA
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):649-660. PubMed ID: 31916131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and Functional Relevance of Na
    Hartmann N; Knierim M; Maurer W; Dybkova N; Hasenfuß G; Sossalla S; Streckfuss-Bömeke K
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of long QT syndrome-associated SCN5A variants in patients with early-onset lone atrial fibrillation.
    Olesen MS; Yuan L; Liang B; Holst AG; Nielsen N; Nielsen JB; Hedley PL; Christiansen M; Olesen SP; Haunsø S; Schmitt N; Jespersen T; Svendsen JH
    Circ Cardiovasc Genet; 2012 Aug; 5(4):450-9. PubMed ID: 22685113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of a Primary Role for SCN10A Mutations in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
    Te Riele AS; James CA; Murray B; Tichnell C; Amat-Alarcon N; Burks K; Tandri H; Calkins H; Polydefkis M; Judge DP
    J Cardiovasc Transl Res; 2016 Feb; 9(1):87-9. PubMed ID: 26733327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Na
    Pabel S; Ahmad S; Tirilomis P; Stehle T; Mustroph J; Knierim M; Dybkova N; Bengel P; Holzamer A; Hilker M; Streckfuss-Bömeke K; Hasenfuss G; Maier LS; Sossalla S
    Basic Res Cardiol; 2020 Feb; 115(2):20. PubMed ID: 32078054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IKs Gain- and Loss-of-Function in Early-Onset Lone Atrial Fibrillation.
    Steffensen AB; Refsgaard L; Andersen MN; Vallet C; Mujezinovic A; Haunsø S; Svendsen JH; Olesen SP; Olesen MS; Schmitt N
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):715-23. PubMed ID: 25786344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-operative atrial fibrillation examined using whole-genome RNA sequencing in human left atrial tissue.
    Sigurdsson MI; Saddic L; Heydarpour M; Chang TW; Shekar P; Aranki S; Couper GS; Shernan SK; Muehlschlegel JD; Body SC
    BMC Med Genomics; 2017 May; 10(1):25. PubMed ID: 28464817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation.
    Darbar D; Kannankeril PJ; Donahue BS; Kucera G; Stubblefield T; Haines JL; George AL; Roden DM
    Circulation; 2008 Apr; 117(15):1927-35. PubMed ID: 18378609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Characterization of Rare Variants Implicated in Susceptibility to Lone Atrial Fibrillation.
    Hayashi K; Konno T; Tada H; Tani S; Liu L; Fujino N; Nohara A; Hodatsu A; Tsuda T; Tanaka Y; Kawashiri MA; Ino H; Makita N; Yamagishi M
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1095-104. PubMed ID: 26129877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants.
    Monasky MM; Micaglio E; Vicedomini G; Locati ET; Ciconte G; Giannelli L; Giordano F; Crisà S; Vecchi M; Borrelli V; Ghiroldi A; D'Imperio S; Di Resta C; Benedetti S; Ferrari M; Santinelli V; Anastasia L; Pappone C
    Europace; 2019 Oct; 21(10):1550-1558. PubMed ID: 31292628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.